Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG. (Q47829177)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2005

Language	Label	Description	Also known as
English	Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG.	scientific article published in April 2005

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG. (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

Mycobacterium bovis

1 reference

based on heuristic

inferred from title

Marita Troye-Blomberg

8

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

author name string

Ariane Rodríguez

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

Anna Tjärnlund

2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

Juraj Ivanji

3

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

Mahavir Singh

4

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

Irene García

5

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

Ann Williams

6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

Philip D Marsh

7

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

Carmen Fernández

9

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

23

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

20

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

2565-2572

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

A three-tiered view of the role of IgA in mucosal defense

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Intracellular neutralization of virus by immunoglobulin A antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Role of secretory IgA, secretory component, and eosinophils in mucosal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Secretory IgA antibodies synergize with IgG in promoting ADCC by human polymorphonuclear cells, monocytes, and lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Increase of tuberculous infection in the organs of B cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Immune responses in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

B- and T-cell responses to the mycobacterium surface antigen PstS-1 in the respiratory tract and adjacent tissues. Role of adjuvants and routes of immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Intranasal vaccination of mice against infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

IgA and mucosal defense.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Vγ9 / Vδ2 T lymphocytes reduce the viability of intracellularMycobacterium tuberculosis

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular antibody neutralizes Listeria growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Immunoglobulin A-mediated protection against Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Advances in antibody-mediated immunity againstMycobacterium tuberculosis: implications for a novel vaccine strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

The role of nitric oxide in the immune response of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Mouse IgA inhibits cell growth by stimulating tumor necrosis factor-alpha production and apoptosis of macrophage cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.032

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.11.032

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15780438

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47829177&oldid=2106072855"